Table 3.

Transmitted drug resistance mutation and confer resistance to ART drugs among the ART treatment naïve.

Samples	PI SDRMs	NRTI SDRMs	NNRTI SDRMs	Confer resistance to ART drugs
Manipur005	—	Y115F, M184V	K103N, Y181C, G190A	ABC (H), DDI (L), FTC (H), 3TC (H), EFV (H), ETR (I), NVP (I), RPV (H)
Manipur017	I54V, L76V, I84V	K65R, M184V	Y188L	ABC (H), d4T (I), DDI (H), FTC (H), 3TC (H), TDF (I), EFV (H), ETR (L), NVP (H), RPV (H), ATV/r (H), DRV/r (I), FPV/r (H), IDV/r (H), LPV/r (H), NFV (H), SQV/r (H), TPV/r (I)
Manipur021	—	K219Q	—	AZT (L), d4T (L)
Manipur034	—	K219Q	—	AZT (L), d4T (L)
Manipur056	—	M184V, T215F	Y181C	ABC (L), AZT (I), d4T (I), DDI (L), FTC (H), 3TC (H), EFV (I), ETR (I), NVP (H), RPV (I)

SDRMs were analyzed by using the Calibrated Population Resistance (CPR) tool at HIV standard database (http://cpr.stanford.edu/cpr.cgi). SDRMs, surveillance drug resistance mutations; H, high; I, intermediate; L, low.